Newsletter | October 22, 2026

10.22.26 -- AI, RWE, And IRT Are Exposing Trial Workforce Gaps

THE PEOPLE AND DATA GAPS HOLDING TRIALS BACK

RWE Has A People Problem, Not A Data Volume Problem

AI can surface signals in real-world data, but pharma still needs people to interpret them. Learn why workforce capacity is RWE’s real bottleneck.

 

Why Clinical Research Is Still Missing An Official Job Code

The U.S. lacks an official job code for clinical research professionals. Learn why that gap limits workforce growth, recognition, and career mobility.

AI, SITE OPERATIONS, AND TRIAL FINANCE UNDER PRESSURE

How AI And Synthetic Data Can Improve Trial Feasibility

Use AI, integrated data, and synthetic populations to simulate enrollment and test protocol feasibility before costly recruitment and regulatory risks.

How Automated IRT Can Reduce Site Burden In Trials

Automated IRT can replace manual resupply and forecasting steps, helping sites reduce errors and manage trial supply with greater efficiency.

How Finance Teams Manage Global Trial Payments And VAT

Global site payments bring lump-sum invoices, multiple languages, and VAT complexity. Learn how streamlined workflows reduce risk and delay.

How HEOR Shapes Evidence-Based Healthcare Decisions

Explore how Health Economics and Outcomes Research informs value, access, and evidence-based decisions across the healthcare ecosystem.

TOOLS FOR DOCUMENT EXCHANGE AND ONCOLOGY DATA CAPTURE

SiteLink For Clinical Trial Document Exchange: Florence

eCOA For Oncology Trials: Restored Control And Quality Science